Nevertheless, these BRAF mutations are commonly present in benign nevi; thus, mutation of BRAF alone is not sufficient to initiate melanomagenesis6,7; therefore, additional oncogenic alterations are required to drive melanocyte transformation and melanoma development8. Here, BRAF is linked to melanoma.